Elizabeth Mittendorf

29PUBLICATIONS

278CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsCancer cell biologyTumour immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (29)

Sort by Publication Date:

|Jun 05, 2026

Longitudinal multi-platform profiling reveals temporal dynamics of HER2, TROP2, PD-L1 and tumor-infiltrating lymphocytes in triple-negative breast cancer.

|May 15, 2026

Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial.

|Apr 30, 2026

A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance Study.

|Nov 04, 2025

Cell populations in human breast cancers are molecularly and biologically distinct with age.

Adrienne Parsons, Esther Sauras Colón, Meghana Manjunath

|Oct 21, 2025

Association of Tumor-Infiltrating Lymphocyte Subtypes with Clinical Characteristics and Prognosis in Young Women with Hormone Receptor-Positive Breast Cancer.

Megan E Tesch, Yue Zheng, Yaileen D Guzman-Arocho

|Jun 04, 2025

Peri-operative atezolizumab in early-stage triple-negative breast cancer: final results and ctDNA analyses from the randomized phase 3 IMpassion031 trial.

Elizabeth A Mittendorf, Zoe June Assaf, Nadia Harbeck

Pageof 5

Frequent Collaborators

13 joint publications

Sara M Tolaney

Nancy U Lin

Nabihah Tayob

Qingchun Jin

Eric Winer

Rinath Jeselsohn

Molly DiLullo

Judy E Garber

Edward T Richardson

Ann H Partridge

Frequent Collaborators

13 joint publications

Sara M Tolaney

9 joint publications

Nancy U Lin

8 joint publications

Nabihah Tayob

4 joint publications

Qingchun Jin